These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Medical strategies for weight loss in the overweight and obese patient. Di Caro S; Hamad GG; Fernstrom MH; Schauer PR; Bonanomi G Minerva Gastroenterol Dietol; 2006 Dec; 52(4):415-30. PubMed ID: 17108871 [TBL] [Abstract][Full Text] [Related]
26. Current pharmacological approaches to the treatment of obesity. Hauner H Int J Obes Relat Metab Disord; 2001 May; 25 Suppl 1():S102-6. PubMed ID: 11466601 [TBL] [Abstract][Full Text] [Related]
27. [The pharmacotherapy of obesity]. Budai KA; Mirzahosseini A; Noszál Béla ; Tóth G Acta Pharm Hung; 2015; 85(1):3-17. PubMed ID: 26137782 [TBL] [Abstract][Full Text] [Related]
29. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study. Kiortsis DN; Tsouli S; Filippatos TD; Konitsiotis S; Elisaf MS Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651 [TBL] [Abstract][Full Text] [Related]
30. Assessment and management of the obese adult female: a clinical update for providers. Salazar SS J Midwifery Womens Health; 2006; 51(3):202-7. PubMed ID: 16647672 [TBL] [Abstract][Full Text] [Related]
31. What role for weight-loss medication? Weighing the pros and cons for obese patients. Wyatt HR; Hill JO Postgrad Med; 2004 Jan; 115(1):38-40, 43-5, 58. PubMed ID: 14755876 [TBL] [Abstract][Full Text] [Related]
33. [No progress without the physician in therapy of obesity]. Schmidt H; Plauth M MMW Fortschr Med; 2000 Jan; 142(4):35-6. PubMed ID: 10850095 [No Abstract] [Full Text] [Related]
34. [Struggle about the best reducing diet, Fat gone by means of more fat?]. Bischoff A MMW Fortschr Med; 2004 Jan; 146(1-2):4-6. PubMed ID: 18441569 [No Abstract] [Full Text] [Related]
35. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat. Scheen AJ; Ernest P Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323 [TBL] [Abstract][Full Text] [Related]
37. Orlistat for obesity. Med Lett Drugs Ther; 1999 Jun; 41(1055):55-6. PubMed ID: 10436767 [No Abstract] [Full Text] [Related]
38. The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions. Coutinho W Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):262-70. PubMed ID: 19466219 [TBL] [Abstract][Full Text] [Related]